Filing Flows › Cerenome (CNSY) › Q4 2024
Cerenome (CNSY) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 31, 2025
Cerenome (CNSY) reported revenue of $1.4M for the fourth quarter 2024 (Q4 2024) and -3% from the quarter before. Operating margin was -276.2%, net loss $3.9M (276.4% of revenue).
Cerenome, Q4 2024: revenue $1.4M, operating margin -276.2%, net loss $3.9M, operating cash flow −$1.2M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | -3% | — |
| Operating profit | −$3.9M | — | — |
| Net earnings | −$3.9M | — | — |
| Operating cash flow | −$1.2M | — | — |
What changed
Revenue was $1.4M in Q4 2024, down 3% from the previous quarter.
Operating costs exceeded revenue by $3.9M, an operating margin of -276.2%. The quarter ended with a net loss of $3.9M, wider than the previous quarter's $2.9M loss.
Operating cash flow was −$1.2M. Non-cash charges added back $199K of depreciation and amortization and $128K of share-based compensation. Working capital and other items added $2.4M. Capital expenditures of $11K exceeded it, leaving free cash flow of −$1.2M.
Questions
What was Cerenome's revenue in the fourth quarter 2024?
Cerenome (CNSY) reported revenue of $1.4M for the fourth quarter 2024 (Q4 2024) and -3% from the quarter before.
Was Cerenome profitable in the fourth quarter 2024?
Operating loss was $3.9M (-276.2% of revenue) and net loss $3.9M.
Source: Cerenome 10-K on SEC EDGAR.